Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quintiles Transnational Holdings Inc (NYSE:Q)

57.50
Delayed Data
As of Feb 05
 -2.03 / -3.41%
Today’s Change
56.66
Today|||52-Week Range
80.45
-16.25%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$7.1B

Company Description

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. The company operates through Product Development and Integrated Healthcare Services segments. Its Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. Its Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

Contact Information

Quintiles Transnational Holdings, Inc.
4820 Emperor Boulevard
Durham North Carolina 27703
P:(919) 998-2000
Investor Relations:

Employees

Shareholders

Other institutional37.51%
Mutual fund holders33.18%
Individual stakeholders29.96%

Top Executives

Thomas H. PikeChief Executive Officer & Director
Kevin K. GordonChief Operating Officer
Michael R. McDonnellChief Financial Officer
Richard ThomasPresident-Technology & Solutions
Alejandro MartinezChief Information Officer